Bruce McClenathan

885 total citations · 1 hit paper
7 papers, 533 citations indexed

About

Bruce McClenathan is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Bruce McClenathan has authored 7 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Epidemiology, 2 papers in Infectious Diseases and 2 papers in Pharmacology. Recurrent topics in Bruce McClenathan's work include Influenza Virus Research Studies (3 papers), Viral Infections and Immunology Research (2 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Bruce McClenathan is often cited by papers focused on Influenza Virus Research Studies (3 papers), Viral Infections and Immunology Research (2 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Bruce McClenathan collaborates with scholars based in United States. Bruce McClenathan's co-authors include Limone Collins, Renata J.M. Engler, Leslie T. Cooper, Margaret A. K. Ryan, David Hrncir, Jay R Montgomery, Donna L. Hoffman, Nehkonti Adams, Michael Platzer and Thomas Beltran and has published in prestigious journals such as PLoS ONE, Vaccine and JAMA Cardiology.

In The Last Decade

Bruce McClenathan

7 papers receiving 512 citations

Hit Papers

Myocarditis Following Immunization With mRNA COVID-19 Vac... 2021 2026 2022 2024 2021 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruce McClenathan United States 5 384 340 134 103 66 7 533
David Hrncir United States 5 307 0.8× 257 0.8× 114 0.9× 81 0.8× 45 0.7× 9 447
Jay R Montgomery United States 9 315 0.8× 258 0.8× 167 1.2× 81 0.8× 84 1.3× 12 615
George A. Diaz United States 5 218 0.6× 152 0.4× 80 0.6× 36 0.3× 41 0.6× 7 372
Beng Beng Ong Australia 8 295 0.8× 384 1.1× 28 0.2× 15 0.1× 144 2.2× 16 565
Melisa D. Rett United States 13 265 0.7× 48 0.1× 65 0.5× 35 0.3× 161 2.4× 16 548
Ko‐Yung Sit Hong Kong 6 492 1.3× 100 0.3× 43 0.3× 30 0.3× 145 2.2× 12 671
David Leeman United Kingdom 8 521 1.4× 52 0.2× 74 0.6× 36 0.3× 43 0.7× 15 693
Stéphane Marot France 10 314 0.8× 23 0.1× 58 0.4× 35 0.3× 33 0.5× 32 378
Anat Wieder-Finesod Israel 7 320 0.8× 20 0.1× 34 0.3× 60 0.6× 26 0.4× 12 355
Gunasekaran Ramakrishnan Belgium 11 131 0.3× 55 0.2× 106 0.8× 24 0.2× 399 6.0× 17 518

Countries citing papers authored by Bruce McClenathan

Since Specialization
Citations

This map shows the geographic impact of Bruce McClenathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce McClenathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce McClenathan more than expected).

Fields of papers citing papers by Bruce McClenathan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce McClenathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce McClenathan. The network helps show where Bruce McClenathan may publish in the future.

Co-authorship network of co-authors of Bruce McClenathan

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce McClenathan. A scholar is included among the top collaborators of Bruce McClenathan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce McClenathan. Bruce McClenathan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
McClenathan, Bruce, et al.. (2023). Incidence of anaphylaxis to YF-VAX® yellow fever vaccination: a retrospective evaluation of vaccine adverse event reports 1999–2018. Journal of Travel Medicine. 31(2). 1 indexed citations
2.
Burgess, Timothy, Stephanie A Richard, Limone Collins, et al.. (2022). 2206. Pragmatic Assessment of Influenza Vaccine Effectiveness in the Department of Defense (PAIVED): Updates from Year 4 of a Multi-site Trial. Open Forum Infectious Diseases. 9(Supplement_2). 2 indexed citations
3.
Montgomery, Jay R, Margaret A. K. Ryan, Renata J.M. Engler, et al.. (2021). Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military. JAMA Cardiology. 6(10). 1202–1202. 370 indexed citations breakdown →
4.
McClenathan, Bruce, et al.. (2019). Herpes zoster after recombinant zoster vaccine: A first case report. The Journal of Allergy and Clinical Immunology In Practice. 8(2). 772–774.e1. 4 indexed citations
5.
Klaric, John, Thomas Beltran, & Bruce McClenathan. (2019). An Association Between Herpes Zoster Vaccination and Stroke Reduction Among Elderly Individuals. Military Medicine. 184(Supplement_1). 126–132. 20 indexed citations
6.
McClenathan, Bruce, Delisha A. Stewart, Wimal Pathmasiri, et al.. (2017). Metabolites as biomarkers of adverse reactions following vaccination: A pilot study using nuclear magnetic resonance metabolomics. Vaccine. 35(9). 1238–1245. 13 indexed citations
7.
Engler, Renata J.M., Michael R. Nelson, Limone Collins, et al.. (2015). A Prospective Study of the Incidence of Myocarditis/Pericarditis and New Onset Cardiac Symptoms following Smallpox and Influenza Vaccination. PLoS ONE. 10(3). e0118283–e0118283. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026